Local Novartis employees await word on layoffs

Swiss drug maker targeting research positions

By Robert Weisman
Globe Staff / October 26, 2011

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Cambridge employees of Swiss drug maker Novartis AG are waiting to find out how a global restructuring - including 2,000 planned job cuts in the United States and Switzerland - will affect company operations in the Boston area. Novartis will save $200 million annually by shedding jobs in research and development, clinical trial monitoring, and other fields on both sides of the Atlantic. The company said it would eliminate 1,100 positions in Switzerland and 900 in the US.

For more from, sign up or log in below

To continue, please sign up or log in to

Access the full articles and quality reporting of The Boston Globe at

Sign up

Unlimited Access to for 4 weeks for only 99¢.

Are you a Boston Globe home delivery subscriber?

Get FREE access as part of your print subscription. subscriber

Click to continue reading this article or to log in to

    waiting for twitterWaiting for Twitter to feed in the latest...